{
    "nct_id": "NCT06162403",
    "official_title": "Exploring the Benefit of Peripheral Nerve Stimulation in Treating Pain from Chemo-induced Peripheral Neuropathy: a Longitudinal Single Center Feasibility Study",
    "inclusion_criteria": "* Participants diagnosed with chronic (≥90 days duration) CIPN (due to either vinca alkaloids, taxanes, bortezomib, thalidomide, platinum-based compounds or ionizing irradiation) of the lower extremity, seen at Pain Management Center at MD Anderson Cancer Center\n* Participants reports baseline pain ≥ 4 (0-10 scale, NRS)\n* Participants between ages 18-85 years old\n* Participants who have completed chemotherapy within the previous year at the time of enrollment\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 85 Years",
    "exclusion_criteria": "* Participants with cognitive dysfunction\n* Participants with recent history (<6 months) of drug or alcohol abuse\n* Participants with open skin lesion or undergoing antibiotic therapy for local for systemic infection\n* Participants with allergies to local anesthesia, steroids, or adhesives\n* Participants with conditions that conflict with the SPRINT PNS System Indications for Use, including Contraindications and Warnings.",
    "miscellaneous_criteria": ""
}